Partner Content Partner Content 3rd Annual AI-ML Drug Discovery & Development Summit Discover Case Studies of Machine Learning in Action
Events Partner Content 13th Annual Pharma Resource Planning and Portfolio Managemen... Prioritizing Projects with Tools, Data, and Governance
Partner Content Partner Content Understanding the evolving CAR-T market In August 2017, Novartis made history after receiving FDA approval for Kymriah, the world’s first chimeric antigen receptor T-cell (CAR-T) therapy.
News BioNTech and Vir prepare mega-IPOs after flurry of launches Two of the largest-ever biotech initial public offerings (IPOs) are scheduled to go ahead in the coming week, after a flurry of smaller stock market launches last week.
Events Partner Content J+D Forecasting bring their Face-to-Face Pharma training to ... Face-to-Face Pharma Forecasting Training in Boston
News Beacon's XLRP gene therapy set for filing after phase 3 win Beacon is preparing to file for approval of its gene therapy for X-linked retinitis pigmentosa, after reporting encouraging phase 3 data.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
